Bone Resorption
Anabolic, antiresorptive agents the 'ideal one-two punch' for osteoporosis
DESTIN, Fla. — Patients with osteoporosis may benefit from treatment initiation with an anabolic agent followed by an antiresorptive agent, according to a speaker at the Congress of Clinical Rheumatology East.
Higher dairy intake during pregnancy maintains bone formation
A dairy food-based nutrition and exercise intervention during pregnancy that optimized protein and calcium intake improved mothers’ bone health compared with usual care, according to a study in the American Journal of Clinical Nutrition.
Bone turnover markers decreased in children with type 1 diabetes
A cohort of children and adolescents with type 1 diabetes had markers of bone formation and bone resorption that were significantly decreased compared with children without diabetes, independent of diabetes duration and Tanner stages, according to findings published in Pediatric Diabetes.
Liraglutide shows antiresorptive effect on bone in type 2 diabetes
A cohort of adults with type 2 diabetes assigned the GLP-1 receptor agonist liraglutide for 26 weeks experienced a preservation in hip and spine bone mineral density and no changes in bone resorption markers despite weight loss, suggesting the drug may have an antiresorptive effect, according to findings published in Bone.